Desktop humidifier,
does it really help with Longer noninvasive tear-film breakup time after one hour of screen work?
research showsThe grade is C with 50 points. In a 31-person trial, first noninvasive breakup time immediately after one hour of screen work was 9.65±2.55 seconds with humidification versus 6.20±2.45 without, and 8.13±3.10 versus 5.41±1.91 at 1.5 hours. The contrast was large, but this was a surrogate test from one tiny manufacturer-funded study whose registration became public the day after manuscript submission.
ads claimThe finding does not establish equivalent effects for all mini humidifiers. It tested one EYE MOIST model, 31 participants, and a short laboratory measure, not long-term symptoms, corneal injury, or work performance.
Useful facts when choosing a product
- The tested product was the Kaltech EYE MOIST photocatalytic micro-mist humidifier.
- Relative humidity near the face changed by +22.6±3.5% with mist and -1.5±2.8% without mist.
- No adverse events were observed during or after the procedure.
Chamgap Semantic Classification Code
Candidate index · review held
UNK.photocatalytic-micro-mist-desktop-humidifier-operated-near-the-face-during-a-visual-display-terminal-task.UNK.longer-noninvasive-tear-film-breakup-time-after-of-screen-work.assess.UNKUnknown > photocatalytic micro-mist desktop humidifier operated near the face during a visual display terminal task > Unknown > Longer noninvasive tear-film breakup time after of screen work > Association or change assessment > Unknown
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
The 2024 RCT by Arita R and Fukuoka S assigned 31 participants to mist on, n=15, or mist off, n=16, during one hour of VDT work and analyzed all participants. First breakup time was 9.65±2.55 versus 6.20±2.45 seconds immediately, P=.001, and 8.13±3.10 versus 5.41±1.91 at 1.5 hours, P=.025. Relative humidity around the face changed by +22.6±3.5% versus -1.5±2.8%. The paper's statistical-analysis section calls NIBUT-first primary, but its status in the protocol at registration was not verified. Kaltech funded the study. The conflict statement says, "R.A. was a consultant for Kaltech Corporation. S.F. received an honorarium from Kaltech Corporation."
Why this is classified as C (50)
Large short-term surrogate differences were limited by a 31-person manufacturer-only trial and post hoc public registration, giving C with 50 points.
Counterpoint. Immediate symptoms improved, but the 1.5-hour symptom contrast was null and no durable clinical outcome was measured.
Rejudgment record. Cross-check applied — Cross-checked analyzed sample, NIBUT-first values, local humidity, funding, conflicts, adverse events, and registration timing against the PMC paper and UMIN record
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
| Replication | R1 | Single confirmatory trial |
| Independence | I0 | Evidence comes only from manufacturer studies |
| Effect size | E+ | Meets the clinically important threshold |
Stored derived and displayed grades match; this is not a current recalculation or validity check (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Longer NIBUT-first after one hour of VDT work | C | Large contrasts were present immediately and at 1.5 hours in one small manufacturer trial. |
| Durable improvement in dry-eye symptoms | ? | Long-term symptom outcomes were not measured. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Arita R, Fukuoka S. 2024 | Envelope-allocated randomized trial of mist on versus off; registry disclosure followed manuscript submission, and the primary outcome in the protocol at registration was not verified | 31 randomized and analyzed, 15 versus 16 | Funded by Kaltech Corporation; conflict statement: "R.A. was a consultant for Kaltech Corporation. S.F. received an honorarium from Kaltech Corporation." | NIBUT-first identified as primary in the paper's statistical-analysis section; secondary NIBUT-average and symptoms | NIBUT-first 9.65±2.55 versus 6.20±2.45 seconds immediately, P=.001; 8.13±3.10 versus 5.41±1.91 at 1.5 hours, P=.025 | Only direct small manufacturer-funded surrogate trial |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-15).
Final verification and publication gate: Codex · Evidence date: 2026-08-15 · Corrections: none
Cite this verdict
[Chamgap] Desktop humidifier x tear-film stability during screen work — Evidence Grade C·50. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/eye/photocatalytic-desktop-humidifier-vdt-tear-film-breakup-time/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.